Central Hypothyroidism: When the Pituitary or Hypothalamus Is the Cause

Central hypothyroidism arises from pituitary or hypothalamic dysfunction rather than the thyroid itself. TSH is inappropriately low or normal despite low FT4, so a TSH-only screen will miss it. Monitoring uses free T4 (not TSH), and the workup must include pituitary MRI plus testing of the other pituitary hormones.

Why central hypothyroidism happens

In standard ("primary") hypothyroidism, the thyroid gland itself fails — usually from Hashimoto's autoimmunity — and the pituitary responds by ramping up TSH to drive whatever thyroid tissue is left. The classic lab pattern is high TSH with low free T4 [C5][C6].

Central hypothyroidism inverts the problem. The thyroid gland is healthy, but the signal that tells it to produce hormone is broken at the level of the pituitary (secondary hypothyroidism) or the hypothalamus (tertiary hypothyroidism). The hypothalamus releases TRH, which tells the pituitary to release TSH, which tells the thyroid to make T4 and T3. If any link in that chain breaks, the thyroid stops getting the message [C1][C2].

The lab signature is low free T4 with an inappropriately normal or low TSH [C1][C2][C3]. The TSH is "inappropriate" because, in the face of low FT4, a healthy pituitary should be producing markedly elevated TSH — and it isn't. The TSH that does get released is often biologically less active than in healthy controls, which is one reason serum TSH cannot be used to gauge replacement dose in these patients [C2][C3].

The most common causes [C1][C2][C5]:

• Pituitary tumors — non-functioning pituitary adenomas, macroadenomas compressing normal pituitary tissue, craniopharyngiomas
• Pituitary surgery or radiation to the sellar region (e.g., for adenoma, nasopharyngeal cancer)
• Hypothalamic disease — tumors, congenital syndromes, prior cranial irradiation
• Infiltrative or inflammatory disorders — sarcoidosis, hemochromatosis, lymphocytic hypophysitis, Langerhans cell histiocytosis, IgG4-related disease
• Traumatic brain injury and subarachnoid hemorrhage — under-recognized, with chronic hypopituitarism reported in a meaningful subset of moderate-to-severe TBI survivors [C4]
• Sheehan's syndrome — postpartum pituitary necrosis after severe peripartum hemorrhage
• Congenital — mutations in TSH-beta, TRHR, IGSF1, TBL1X and related genes

Clinical pattern and timeline

Symptoms overlap with primary hypothyroidism — fatigue, cold intolerance, dry skin, constipation, weight gain, slow cognition — but they are often milder for the same degree of FT4 reduction, because residual TSH bioactivity preserves some thyroid output [C2][C3].

What sets central hypothyroidism apart clinically is the company it keeps [C1][C2]. The same lesion that knocks out TSH usually damages other pituitary axes, so patients commonly present with one or more of:

• Secondary adrenal insufficiency — fatigue, low blood pressure, hyponatremia, hypoglycemia
• Hypogonadism — low libido, amenorrhea, erectile dysfunction, infertility
• Growth hormone deficiency — central adiposity, reduced exercise capacity, low IGF-1
• Hyperprolactinemia or hypoprolactinemia — galactorrhea, menstrual irregularity, lactation failure postpartum
• Diabetes insipidus — polyuria, polydipsia (if posterior pituitary or stalk involved)
• Visual field defects or headaches — from sellar mass effect

A timeline clue: in TBI-related central hypothyroidism, symptoms can develop months to years after the initial injury as pituitary function gradually declines [C4]. A patient with low FT4 and a remote history of head trauma, brain surgery, or cranial radiation deserves the central-hypothyroidism workup, not a repeat TSH.

What recovers on adequate levothyroxine

Levothyroxine fully replaces the missing T4 and corrects the downstream symptoms of hypothyroidism in central disease just as it does in primary disease [C1][C3][C6]. Fatigue, cold intolerance, constipation, and dry skin all improve over weeks to months on a correct dose.

The non-thyroid pieces (adrenal, gonadal, growth hormone deficits) require their own replacement and do not respond to thyroxine alone [C1][C2].

The dose monitoring is fundamentally different from primary hypothyroidism:

• TSH is useless for titration in central hypothyroidism — it is already low or normal because the pituitary is the problem. Pushing TSH "into range" by reducing thyroxine will leave the patient under-treated [C1][C2][C3].
• Free T4 is the target. Most guidelines aim for an FT4 in the upper half of the laboratory reference range on stable therapy [C1][C3].
• Free T3, symptoms, resting heart rate, and lipid response complement FT4 when the picture is unclear [C1].

The other critical safety rule: rule out and treat adrenal insufficiency before starting levothyroxine [C1][C2][C3]. Thyroxine accelerates cortisol metabolism. Starting it in an undiagnosed adrenal-insufficient patient can precipitate an adrenal crisis. The standard order is cortisol assessment (morning cortisol, ACTH stim if borderline) first, glucocorticoid replacement if needed, then levothyroxine.

When central hypothyroidism is missed — the differential

A patient with persistent hypothyroid symptoms and a "normal" TSH is the textbook missed case [C1][C2][C5]. Triggers to widen the workup beyond TSH:

1. Symptoms with FT4 below reference range despite TSH normal or low. This is the defining lab pattern of central hypothyroidism [C1].
2. History of pituitary surgery, sellar radiation, traumatic brain injury, or postpartum hemorrhage [C1][C4].
3. Visual field changes, persistent headache, or galactorrhea — pituitary mass effect [C1][C2].
4. Other axes are off — low morning cortisol, low LH/FSH with low estradiol or testosterone, low IGF-1, abnormal prolactin [C1][C2].
5. Children with growth failure, hypoglycemia, prolonged jaundice, or micropenis — congenital central hypothyroidism may not be caught by TSH-based newborn screens used in some programs [C1].

Confirmatory workup includes pituitary MRI, a full pituitary hormone panel (morning cortisol ± ACTH stimulation, LH, FSH, testosterone or estradiol, IGF-1, prolactin), and — in select cases — TRH stimulation testing [C1][C2][C3].

What does NOT help

• Treating central hypothyroidism by chasing TSH. Suppressing FT4 to "normalize" TSH leaves the patient under-treated and symptomatic [C1][C2].
• Adding T3 or desiccated thyroid as first-line. ETA and ATA guidelines recommend levothyroxine monotherapy with FT4-based titration as standard of care; T3 combination is reserved for selected refractory cases [C1][C6].
• Iodine supplements. Central hypothyroidism is not an iodine problem — the gland can make hormone, it just isn't being told to [C5][C7].
• Starting levothyroxine before checking cortisol in a patient with possible panhypopituitarism. This can precipitate adrenal crisis [C1][C2][C3].
• High-dose biotin near lab draws. Biotin distorts FT4 and TSH immunoassays and can fake either pattern; stop 72 hours before blood work [C7].

Practical guidelines

1. Suspect central hypothyroidism whenever FT4 is low and TSH is normal or low, especially with a pituitary or head-injury history [C1][C2][C4].
2. Your endocrinologist will order pituitary MRI plus a full pituitary panel (morning cortisol, ACTH stim if borderline, LH/FSH, sex steroids, IGF-1, prolactin) before settling on a thyroid-only diagnosis [C1][C2].
3. Replace cortisol first if adrenal insufficiency is present, then start levothyroxine [C1][C3].
4. Monitor dose with free T4, not TSH — target the upper half of the reference range with symptoms resolved [C1][C3][C6].
5. Re-test the other pituitary axes annually, or whenever new symptoms appear, since deficiencies can evolve after radiation, surgery, or TBI [C1][C4].
6. Wear medical-alert ID if multiple pituitary deficiencies are confirmed, and your endocrinologist will brief you on stress-dose steroid rules for illness or surgery [C1].

Frequently asked questions

Why is my TSH normal if I have hypothyroidism? In central hypothyroidism, the pituitary itself can't make adequate TSH, so the value looks "normal" despite low FT4. The clinical and biochemical picture — not TSH alone — makes the diagnosis [C1][C2].

Will levothyroxine cure central hypothyroidism? Levothyroxine replaces the missing T4 and resolves the hypothyroid symptoms, but it does not fix the underlying pituitary or hypothalamic lesion. Other hormone deficiencies need their own replacement [C1][C3].

How is my dose adjusted without TSH? Your endocrinologist will titrate to a free T4 in the upper half of the reference range, with symptom relief and a normal resting heart rate as supporting markers [C1][C3][C6].

Is central hypothyroidism dangerous? The hypothyroidism itself responds well to replacement. The risk is in the associated deficiencies — particularly secondary adrenal insufficiency, which can be life-threatening if missed and not stress-dosed during illness [C1][C2].

Can a head injury years ago cause this now? Yes. Hypopituitarism develops in a meaningful fraction of moderate-to-severe TBI survivors, sometimes months to years after the event, which is why endocrine screening is recommended after significant head injury [C4].

Bottom line

Central hypothyroidism is the form of thyroid hormone deficiency where the thyroid is healthy but the pituitary or hypothalamus is not [C1][C2]. Low FT4 with inappropriately normal or low TSH is the signature [C1]. The workup must include pituitary MRI and the other pituitary axes — especially cortisol, which is replaced before levothyroxine is started [C1][C2][C3]. Dosing is monitored with FT4 (not TSH), targeted to the upper half of the reference range [C1][C3][C6]. The hypothyroid symptoms respond to levothyroxine, but the underlying pituitary diagnosis must be tracked over time [C4][C8].